Literature DB >> 31524159

Measuring Alzheimer's Disease and Other Dementias in Diverse Populations Using Medicare Claims Data.

Johanna Thunell1, Patricia Ferido1, Julie Zissimopoulos1,2.   

Abstract

We examined how methods used for identifying dementia in administrative claims affected dementia incidence across racial/ethnic populations using a 100% sample of Medicare beneficiaries (n = 23,793,452). We found levels differed by method from 3.1% annual incidence to 3.6% in 2014. Dementia incidence declined from 2007 to 2014, but choice of method differentially impacted levels and trends by race/ethnicity. Methods using codes for dementia diagnosis and drugs to treat symptoms identified proportionally more Hispanics and Asians with dementia than other race/ethnicities, while codes for dementia diagnosis, drugs, and symptoms identified proportionally more whites and American Indians/Alaska Natives with dementia than other race/ethnicities.

Entities:  

Keywords:  Alzheimer’s disease; dementia; diagnosis; incidence; measurement

Year:  2019        PMID: 31524159      PMCID: PMC6999832          DOI: 10.3233/JAD-190310

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  14 in total

1.  Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.

Authors:  Robb D Kociol; John R Horton; Gregg C Fonarow; Eric M Reyes; Linda K Shaw; Christopher M O'Connor; G Michael Felker; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2011-07-08       Impact factor: 8.790

2.  Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013.

Authors:  Richard A Goodman; Kimberly A Lochner; Madhav Thambisetty; Thomas S Wingo; Samuel F Posner; Shari M Ling
Journal:  Alzheimers Dement       Date:  2016-05-10       Impact factor: 21.566

3.  Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK.

Authors:  Patrick Imfeld; Yolanda B Brauchli Pernus; Susan S Jick; Christoph R Meier
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease.

Authors:  Julie M Zissimopoulos; Douglas Barthold; Roberta Diaz Brinton; Geoffrey Joyce
Journal:  JAMA Neurol       Date:  2017-02-01       Impact factor: 18.302

5.  A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.

Authors:  Wendy L St Peter; Jiannong Liu; Eric Weinhandl; Qiao Fan
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

6.  The association between midlife cardiorespiratory fitness and later life chronic kidney disease: The Cooper Center Longitudinal Study.

Authors:  Laura F DeFina; Carolyn E Barlow; Nina B Radford; David Leonard; Benjamin L Willis
Journal:  Prev Med       Date:  2016-05-31       Impact factor: 4.018

7.  Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease.

Authors:  Christopher M Black; Howard Fillit; Lin Xie; Xiaohan Hu; M Furaha Kariburyo; Baishali M Ambegaonkar; Onur Baser; Huseyin Yuce; Rezaul K Khandker
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment.

Authors:  Igor Akushevich; Arseniy P Yashkin; Julia Kravchenko; Svetlana Ukraintseva; Eric Stallard; Anatoliy I Yashin
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Pain in Community-Dwelling Older Adults with Dementia: Results from the National Health and Aging Trends Study.

Authors:  Lauren J Hunt; Kenneth E Covinsky; Kristine Yaffe; Caroline E Stephens; Yinghui Miao; W John Boscardin; Alex K Smith
Journal:  J Am Geriatr Soc       Date:  2015-07-22       Impact factor: 5.562

10.  The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity.

Authors:  Douglas Barthold; Geoffrey Joyce; Whitney Wharton; Patrick Kehoe; Julie Zissimopoulos
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

View more
  8 in total

1.  Racial/Ethnic Disparities in Length of Life after Dementia Diagnosis: an 18-Year Follow-up Study of Medicare Beneficiaries.

Authors:  Yi Chen; Eileen Crimmins; Patricia Ferido; Julie M Zissimopoulos
Journal:  Lancet Reg Health Am       Date:  2022-01-08

2.  Benzodiazepine use and the risk of dementia.

Authors:  Geoffrey Joyce; Patricia Ferido; Johanna Thunell; Bryan Tysinger; Julie Zissimopoulos
Journal:  Alzheimers Dement (N Y)       Date:  2022-07-20

3.  Validation of Claims Algorithms to Identify Alzheimer's Disease and Related Dementias.

Authors:  Ellen P McCarthy; Chiang-Hua Chang; Nicholas Tilton; Mohammed U Kabeto; Kenneth M Langa; Julie P W Bynum
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-06-01       Impact factor: 6.591

4.  Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.

Authors:  Douglas Barthold; Geoffrey Joyce; Patricia Ferido; Emmanuel F Drabo; Zachary A Marcum; Shelly L Gray; Julie Zissimopoulos
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Dementia and Early Do-Not-Resuscitate Orders Associated With Less Intensive of End-of-Life Care: A Retrospective Cohort Study.

Authors:  Elizabeth A Luth; Cynthia X Pan; Martin Viola; Holly G Prigerson
Journal:  Am J Hosp Palliat Care       Date:  2021-01-20       Impact factor: 2.500

6.  Patterns of incident dementia codes during the COVID-19 pandemic at an integrated healthcare system.

Authors:  Soo Borson; Aiyu Chen; Susan E Wang; Huong Q Nguyen
Journal:  J Am Geriatr Soc       Date:  2021-10-25       Impact factor: 5.562

7.  Medicare's Annual Wellness Visit and diagnoses of dementias and cognitive impairment.

Authors:  Johanna A Thunell; Mireille Jacobson; Elizabeth B Joe; Julie M Zissimopoulos
Journal:  Alzheimers Dement (Amst)       Date:  2022-09-14

8.  Association between exenatide use and incidence of Alzheimer's disease.

Authors:  Bo Zhou; Julie Zissimopoulos; Hasan Nadeem; Matthew A Crane; Dana Goldman; John A Romley
Journal:  Alzheimers Dement (N Y)       Date:  2021-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.